VC, Investments
– The company also raised NIS 63 million in future options and hopes to bring two products to the European market by 2015. –...
Hi, what are you looking for?
– The company also raised NIS 63 million in future options and hopes to bring two products to the European market by 2015. –...
– The Adverse Event Profile for Rolapitant was Consistent with Earlier Clinical Trials. Preparations Continue in Support of Submission of a New Drug Application...
– – /By Johanna Weiß/ “Break a leg” may be what people say when they want to wish someone luck, but breaking a leg is...
– Blumenthal , cofounder of the online spectacle portal has seen his company’s total funding level rise to more than $110 million since 2010....
– The 12-week Phase IIb study involving 79 patients with active rheumatoid arthritis met all its primary efficacy endpoints. – Can-Fite BioPharma Ltd. (TASE:CFBI; Bulletin...
– Facebook Joins S&P 500 Facebook has been in the news quite a bit this week. First, Standard & Poor‘s (S&P), a division...
– Moovit will use the investment to enhance services in the 100 cities in which it operates, while expanding to new markets. – –...
– Six weeks after the Nasdaq IPO of the DIY website developer, the share price has risen 67% and the market cap is above...
– The funding will be used by Dr. Ciechanover in the development of drugs for the treatment of Kidney disorders as well as Ovarian...
– – Just over two weeks ago, on December 3rd, Jewish Business News reported on the launching of an initial public offering (IPO) that...